Lung regeneration therapy for chronic obstructive pulmonary disease

Tuberculosis and Respiratory Diseases

Volumn 80, Issue 1, 2017, Pages 1-10

  Oh, Dong Kyu ^a   Kim, You Sun ^b,c   Oh, Yeon Mok ^a,b,c  

^a Asan Medical Center   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

Cell and tissue based therapy; Chronic obstructive; Drug therapy; Emphysema; Lung; Pulmonary disease; Regeneration; Regenerative Medicine; Retinoids; Stem Cells

Indexed keywords

ESTROGEN; FIBROBLAST GROWTH FACTOR 2; ISOTRETINOIN; PALOVAROTENE; PLACEBO; RETINOIC ACID; SCATTER FACTOR;

ADIPOSE DERIVED STEM CELL; ALPHA 1 ANTITRYPSIN DEFICIENCY; BLEOMYCIN-INDUCED PULMONARY FIBROSIS; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CHRONIC OBSTRUCTIVE LUNG DISEASE; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG MEGADOSE; ELASTASE-INDUCED EMPHYSEMA; EMBRYONIC STEM CELL; FORCED EXPIRATORY VOLUME; HUMAN; IN VIVO GENE TRANSFER; LOW DRUG DOSE; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG REGENERATION; LUNG RESECTION; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OVARIECTOMY; REVIEW; STEM CELL CULTURE; TISSUE REGENERATION; UNSPECIFIED SIDE EFFECT;

EID: 85009921583     PISSN: 17383536     EISSN: None     Source Type: Journal    
DOI: 10.4046/trd.2017.80.1.1     Document Type: Review

References (39)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Internet]. Global Initiative for Chronic Obstructive Lung Disease; 2015 [cited 2015 Dec 21]. Available from: http://www.goldcopd.org/up-loads/users/files/GOLD-Report-2015-Sept2.pdf.
2. Kotton DN, Morrisey EE Lung regeneration: mechanisms, applications and emerging stem cell populations. Nat Med 2014; 20:822-32.
3. Rock J, Konigshoff M. Endogenous lung regeneration: potential and limitations. Am J Respir Crit Care Med 2012; 186:1213-9.
4. Adamson IY, Bowden DH Derivation of type 1 epithelium from type 2 cells in the developing rat lung. Lab Invest 1975; 32:736-45.
5. Voss GJ, Kump DK, Walker J.A., Voss SR. Variation in salamander tail regeneration is associated with genetic factors that determine tail morphology. PLoS One 2013; 8:e67274.
6. Laros CD, Westermann CJ Postpneumonectomy compensatory lung growth. Am Rev Respir Dis 1989; 139:1569-70.
7. Landesberg LJ, Ramalingam R, Lee K., Rosengart TK, Crystal RG. Upregulation of transcription factors in lung in the early phase of postpneumonectomy lung growth. Am J Physiol Lung Cell Mol Physiol 2001; 281:L1138-49.
8. Kho AT, Liu K, Visner G., Martin T, Boudreault F. Identification of dedifferentiation and redevelopment phases during post-pneumonectomy lung growth. Am J Physiol Lung Cell Mol Physiol 2013; 305:L542-54.
9. Wolff JC, Wilhelm J, Fink L, Seeger W, Voswinckel R. Comparative gene expression profiling of post-natal and post-pneumonectomy lung growth. Eur Respir J 2010; 35:655-66.
10. Roszell B, Mondrinos MJ, Seaton A, Simons D.M., Koutzaki SH, Fong GH, et al. Efficient derivation of alveolar type II cells from embryonic stem cells for in vivo application. Tissue Eng Part A 2009; 15:3351-65.
11. Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell 2012; 10:709-16.
12. Katsha AM, Ohkouchi S, Xin H., Kanehira M, Sun R, Nukiwa T., et al. Paracrine factors of multipotent stromal cells ameliorate lung injury in an elastase-induced emphysema model. Mol Ther 2011; 19:196-203.
13. Huh JW, Kim SY, Lee J.H., Lee JS, Van Ta Q, Kim M, et al Bone marrow cells repair cigarette smoke-induced emphysema in rats. Am J Physiol Lung Cell Mol Physiol 2011; 301:L255-66.
14. Schweitzer KS, Johnstone BH, Garrison J, Rush N.I., Cooper S., Traktuev DO, et al. Adipose stem cell treatment in mice attenuates lung and systemic injury induced by cigarette smoking. Am J Respir Crit Care Med 2011; 183:215-25.
15. Kim YS, Kim JY, Huh J.W., Lee SW, Choi SJ, Oh YM. The therapeutic effects of optimal dose of mesenchymal stem cells in a murine model of an elastase induced-emphysema. Tuberc Respir Dis 2015; 78:239-45.
16. Kim YS, Kim JY, Shin D.M., Huh JW, Lee SW, Oh YM. Tracking intravenous adipose-derived mesenchymal stem cells in a model of elastase-induced emphysema. Tuberc Respir Dis 2014; 77:116-23.
17. Murphy MB, Moncivais K, Caplan AI Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine. Exp Mol Med 2013; 45:e54.
18. Guan XJ, Song L, Han F.F., Cui ZL, Chen X, Guo XJ, et al Mesenchymal stem cells protect cigarette smoke-damaged lung and pulmonary function partly via VEGF-VEGF receptors. J Cell Biochem 2013; 114:323-35.
19. Massaro GD, Massaro D. Retinoic acid treatment partially rescues failed septation in rats and in mice. Am J Physiol Lung Cell Mol Physiol 2000; 278:L955-60.
20. Massaro GD, Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat Med 1997; 3:675-7.
21. Mason RJ, Leslie CC, McCormick-Shannon K, Deterding R.R., Nakamura T., Rubin JS, et al. Hepatocyte growth factor is a growth factor for rat alveolar type II cells. Am J Respir Cell Mol Biol 1994; 11:561-7.
22. Shigemura N, Sawa Y, Mizuno S., Ono M, Ohta M, Nakamura T., et al. Amelioration of pulmonary emphysema by in vivo gene transfection with hepatocyte growth factor in rats. Circulation 2005; 111:1407-14.
23. Hegab AE, Kubo H, Yamaya M., Asada M, He M, Fujino N., et al. Intranasal HGF administration ameliorates the physiologic and morphologic changes in lung emphysema. Mol Ther 2008; 16:1417-26.
24. Morino S, Nakamura T, Toba T., Takahashi M, Kushibiki T, Tabata Y., et al. Fibroblast growth factor-2 induces recovery of pulmonary blood flow in canine emphysema models. Chest 2005; 128:920-6.
25. Lee BJ, Moon HG, Shin T.S., Jeon SG, Lee EY, Gho YS, et al Protective effects of basic fibroblast growth factor in the development of emphysema induced by interferon-gamma. Exp Mol Med 2011; 43:169-78.
26. Guzy RD, Stoilov I, Elton T.J., Mecham R P, Ornitz DM. Fibro-blast growth factor 2 is required for epithelial recovery, but not for pulmonary fibrosis, in response to bleomycin. Am J Respir Cell Mol Biol 2015; 52:116-28.
27. Massaro D, Massaro GD Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am J Physiol Lung Cell Mol Physiol 2004; 287:L1154-9.
28. Hare JM, Traverse JH, Henry T.D., Dib N., Strumpf RK, Schulman SP, et al. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009; 54:2277-86.
29. Weiss DJ, Casaburi R, Flannery R., LeRoux-Williams M, Tashkin DP. A placebo-controlled, randomized trial of mesenchymal stem cells in COPD. Chest 2013; 143:1590-8.
30. Ribeiro-Paes J.T., Bilaqui A, Greco O.T., Ruiz MA, Marcelino MY, Stessuk T, et al Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema. Int J Chron Obstruct Pulmon Dis 2011; 6:63-71.
31. Stessuk T, Ruiz MA, Greco O.T., Bilaqui A., Ribeiro-Paes MJ, Ribeiro-Paes JT. Phase I clinical trial of cell therapy in patients with advanced chronic obstructive pulmonary disease: follow-up of up to 3 years. Rev Bras Hematol Hemoter 2013; 35:352-7.
32. Mao JT, Goldin JG, Dermand J, Ibrahim G., Brown MS, Emerick A, et al. A pilot study of all-trans-retinoic acid for the treatment of human emphysema. Am J Respir Crit Care Med 2002; 165:718-23.
33. Roth MD, Connett JE, D'Armiento JM, Foronjy RF, Friedman P.J., Goldin JG, et al. Feasibility of retinoids for the treatment of emphysema study. Chest 2006; 130:1334-45.
34. Jones PW, Rames AD TESRA (Treatment of Emphysma with a Selective Retinoid Agonist) study results. Am J Respir Crit Care Med 2011; 183:A6418.
35. Stolk J, Stockley RA, Stoel B.C., Cooper BG, Piitulainen E, Seersholm N, et al Randomised controlled trial for emphysema with a selective agonist of the gamma-type retinoic acid receptor. Eur Respir J 2012; 40:306-12.
36. Lippman SM, Lee JJ, Karp D.D., Vokes EE, Benner SE, Goodman GE, et al Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer. J Natl Cancer Inst 2001; 93:605-18.
37. Warrell RP J.r., de The H, Wang ZY, Degos L. Acute promyelocytic leukemia. N Engl J Med 1993; 329:177-89.
38. Mercado N, Ito K, Barnes PJ Accelerated ageing of the lung in COPD: new concepts. Thorax 2015; 70:482-9.
39. Tashiro J, Elliot SJ, Gerth D.J., Xia X., Pereira-Simon S, Choi R, et al Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis. Transl Res 2015; 166:554-67.